NAFDAC approves emergency use of three additional Covid-19 vaccines for Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) vaccine committee has approved the emergency use of additional three new Covid-19 vaccines. The vaccines include the Moderna (Rovi Pharma Madrid, Spain) AstraZeneca AZD1222 [SK Bioscience Co Limited